Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Alan E. Smith currently holds 37,621 shares of GENZYME CORP (GENZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alan E. Smith has been a net seller of GENZ stock. They have purchased $0 and sold $12.9M worth of shares.
Alan E. Smith's most recent insider trade was on Apr 4, 2011, when they sold 37,621 shares at $74.00 per share.
Alan E. Smith serves as Executive at GENZYME CORP (GENZ). They have executed 30 insider transactions totaling $12.9M over their tenure at the company.
Alan E. Smith holds the position of Executive at GENZYME CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Alan E. Smith has shown a selling trading pattern, with $0 in total purchases and $12.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Alan E. Smith was on Dec 8, 2008, when they sold $3.6M worth of GENZ shares. This transaction involved 55,521 shares at $65.17 per share.
Alan E. Smith currently owns 37,621 shares of GENZYME CORP (GENZ), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Alan E. Smith's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Alan E. Smith has 30 Form 4 filings on record as an insider at GENZYME CORP.
Set alerts for Alan E. Smith and 40,000+ other insiders.